Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: June

Request Number: A-2023-001277

Request Summary: New Drug Submission (NDS) for avapritinib filed by Blueprint Medicines Corporation was accepted into review by Health Canada in or around November 2023. Provide a non-annotated copy of the most recent Certified Product Information Document (CPID) submitted for the Avapritinib NDS.

Disposition: Disclosed in part

Number of pages: 43

Date modified: